ovarian neoplasm
|
0.300 |
Biomarker
|
disease |
CTD_human |
URI is an oncogene amplified in ovarian cancer cells and is required for their survival.
|
21397856 |
2011 |
Malignant neoplasm of ovary
|
0.300 |
Biomarker
|
disease |
CTD_human |
URI is an oncogene amplified in ovarian cancer cells and is required for their survival.
|
21397856 |
2011 |
Cognition Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
In conclusion, co-treatment with buspirone and APPDs outperformed APPDs alone in improving cognitive deficit and reducing family burden of schizophrenia.
|
31101513 |
2019 |
Schizophrenia
|
0.010 |
Biomarker
|
disease |
BEFREE |
In conclusion, co-treatment with buspirone and APPDs outperformed APPDs alone in improving cognitive deficit and reducing family burden of schizophrenia.
|
31101513 |
2019 |
Impaired cognition
|
0.010 |
Biomarker
|
disease |
BEFREE |
In conclusion, co-treatment with buspirone and APPDs outperformed APPDs alone in improving cognitive deficit and reducing family burden of schizophrenia.
|
31101513 |
2019 |
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Human mesenchymal stem cells (MSCs) represent a novel carrier for gene therapy and apoptin is a potential tumor-selective apoptosis-inducing protein.
|
25816208 |
2015 |
Malignant neoplasm of urinary bladder
|
0.010 |
Biomarker
|
disease |
BEFREE |
To investigate whether apoptin is a apoptosis-inducing protein with a potential for bladder cancer therapy.
|
22502656 |
2012 |
Bladder Neoplasm
|
0.010 |
Biomarker
|
disease |
BEFREE |
To investigate whether apoptin is a apoptosis-inducing protein with a potential for bladder cancer therapy.
|
22502656 |
2012 |
Carcinoma of bladder
|
0.010 |
Biomarker
|
disease |
BEFREE |
To investigate whether apoptin is a apoptosis-inducing protein with a potential for bladder cancer therapy.
|
22502656 |
2012 |
Pancreatic carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Enhancing apoptosis and overcoming resistance of gemcitabine in pancreatic cancer with bortezomib: a role of death-associated protein kinase-related apoptosis-inducing protein kinase 1.
|
20210246 |
2010 |
Malignant neoplasm of pancreas
|
0.010 |
Biomarker
|
disease |
BEFREE |
Enhancing apoptosis and overcoming resistance of gemcitabine in pancreatic cancer with bortezomib: a role of death-associated protein kinase-related apoptosis-inducing protein kinase 1.
|
20210246 |
2010 |
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
In contrast TAT-apoptin migrated from the cytoplasm to the nucleus of Saos-2 and HSC-3 cancer cells resulting in apoptosis after 24 h. This study shows that apoptin is a powerful apoptosis-inducing protein with a potential for cancer therapy.
|
14691460 |
2004 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
In contrast TAT-apoptin migrated from the cytoplasm to the nucleus of Saos-2 and HSC-3 cancer cells resulting in apoptosis after 24 h. This study shows that apoptin is a powerful apoptosis-inducing protein with a potential for cancer therapy.
|
14691460 |
2004 |
Trichohepatoenteric Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations of the tumor necrosis factor receptor super family member 6 (TNFRSF6) gene, coding for the apoptosis-inducing protein Fas (Apo-1, CD95) are involved in the physiopathology of the syndrome, although the complete mechanism by which the syndrome is caused has not yet been unraveled.
|
12608883 |
2003 |
Malignant neoplasm of prostate
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Adenovirus-mediated overexpression of the apoptosis-inducing protein Bax can induce apoptosis in prostate cancer cell lines.
|
11535706 |
2001 |
Prostate carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Adenovirus-mediated overexpression of the apoptosis-inducing protein Bax can induce apoptosis in prostate cancer cell lines.
|
11535706 |
2001 |
Anisakiasis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Purification and cloning of an apoptosis-inducing protein derived from fish infected with Anisakis simplex, a causative nematode of human anisakiasis.
|
10903755 |
2000 |